Skip to main content

Table 2 In vivo (N = 10) PC-MRI measures of total flow and peak velocity.

From: Convex gradient optimization for increased spatiotemporal resolution and improved accuracy in phase contrast MRI

  FCFE CVX-SR CVX-TR
Total Flow (mL)
aAo 89.0 ± 18.2 95.9 ± 19.4 93.5 ± 17.9
PA 92.6 ± 18.5 100.1 ± 20.1 97.2 ± 18.0†,‡
RPA 48.1 ± 9.5 52.5 ± 9.9 50.9 ± 9.5†,‡
LPA 44.3 ± 8.7 47.7 ± 10.2 46.4 ± 9.0
Peak Velocity (cm/s)
aAo 117.2 ± 17.2 121.6 ± 15.3 127.3 ± 15.8†,‡
PA 87.0 ± 11.8 90.0 ± 13.5 95.4 ± 15.4†,‡
RPA 93.8 ± 15.9 97.1 ± 16.8 104.7 ± 21.7†,‡
LPA 95.3 ± 18.0 99.7 ± 19.8 107.2 ± 19.9†,‡
  1. Data are expressed as mean ± standard deviation P < 0.05 shows a statistical significant difference compared to FCFE. P < 0.05 shows a statistical significant difference compared to CVX-SR.